Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaktinib Cream in Mild to Moderate Atopic Dermatitis
NCT04435392Phase 2Completed
- Sponsor
- Zelgen
- Start
- Oct 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jaktinib in atopic dermatitis (AD), sponsored by Zelgen. Started Oct 2020; status: completed.
02
Drugs
jaktinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04435392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435392.